Stimuli-Responsive Nasal in situ Gel Drug Delivery Systems: from Material Design to Clinical Translation
International Journal of Nanomedicine · 2026-04 · Volume 21 · 1-19
DOI: 10.2147/ijn.s602581 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-04. Verfasst von Jiansong He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China. Hauptthemen laut MEDLINE: Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
- Department of Traditional Chinese Medicine, Qinzhou Maternal and Child Health Care Hospital, Qinzhou, People's Republic of China.
ORCID-Profile: Jiansong He, Taotao Liu, Heng Long
Zitieren
APA
He, J., Wei, J., Chen, J., Liu, T., Long, H., & Wei, W. (2026). Stimuli-Responsive Nasal in situ Gel Drug Delivery Systems: from Material Design to Clinical Translation. International Journal of Nanomedicine, Volume 21, 1-19. https://doi.org/10.2147/ijn.s602581
Vancouver
He J, Wei J, Chen J, Liu T, Long H, Wei W. Stimuli-Responsive Nasal in situ Gel Drug Delivery Systems: from Material Design to Clinical Translation. International Journal of Nanomedicine. 2026;Volume 21:1-19. doi:10.2147/ijn.s602581
BibTeX
@article{He2026,
author = {He, Jiansong and Wei, Juan and Chen, Jiemei and Liu, Taotao and Long, Heng and Wei, Weipeng},
title = {Stimuli-Responsive Nasal in situ Gel Drug Delivery Systems: from Material Design to Clinical Translation},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--19},
doi = {10.2147/ijn.s602581}
}
EUVIMED